Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Webcast Replays
AVBCC COVID-19 Webcast Series Replays
August 4, 2020: Revenue Cycle Management Update: COVID-19 Recovery, the Road Ahead
By
Parag Shah
;
Nirav Shah, MBA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
When oncology practices, ranging from small community clinics to larger hospital-based programs, were required to adapt their systems virtually overnight in response to the COVID-19 health crisis, almost no one anticipated that these would be long-term changes. However, as September approaches with no end in sight, it has become clear that oncologists will need to adapt revenue cycle management to long-term pandemic-related changes.
Read Bio
July 30, 2020: Update from Community Cancer Care Providers: COVID-19 Recovery, the Road Ahead
By
Michael Diaz, MD
;
Barbara L. McAneny, MD
;
Ted Okon, MBA
;
Kashyap Patel, MD
;
Debra Patt, MD, PhD, MBA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
As many full-service hospitals and health systems remain overwhelmed due to the COVID-19 pandemic, community cancer providers have been able to offer certain services to patients that may not be available at other institutions. How have these providers adapted to meet patients’ changing needs, and how are they keeping their doors open under unprecedented pressure?
Read Bio
July 29, 2020: Comprehensive Cancer Care Centers and Integrated Delivery Systems Update: COVID-19 Recovery, the Road Ahead
By
Al B. Benson III, MD
;
Howard “Skip” Burris, III, MD, FACP, FASCO
;
Christian Downs, MHA, JD
;
Timothy Kubal, MBA, MD
;
Julian Schink, MD
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
From shuttered laboratory experiments and interrupted clinical trial enrollments to a “shadow curve” of delayed cancer diagnoses, comprehensive cancer centers and integrated delivery networks (IDNs) across the country continue to grapple with the fallout from COVID-19.
Read Bio
July 28, 2020: Update from Managed Care Payers: COVID-19 Recovery, the Road Ahead
By
Michael Kolodziej, MD
;
Bryan Loy, MD, MBA
;
Lee N. Newcomer, MD, MHA
;
Steven Peskin, MD, MBA, FACP
;
Michael Sherman, MD, MBA, MS
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.
Read Bio
July 22, 2020: Patient Advocacy Update: COVID-19 Recovery, the Road Ahead
By
Elizabeth Franklin, LGSW, ACSW
;
Patricia J Goldsmith
;
Amy Niles, MBA
;
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.
Read Bio
July 21, 2020: Oncology Pharmacy Update: COVID-19 Recovery, the Road Ahead
By
Scott Freeswick, MS, PharmD
;
Niesha Griffith, RPh, MS, FASHP
;
Chris Marcum, PharmD
;
Ali McBride, PharmD, MBA
;
Stacey McCullough, PharmD
;
Bhavesh Shah, RPh, BCOP
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.
Read Bio
July 15, 2020: Oncology Home Infusion in Post-COVID-19 World: COVID-19 Recovery, the Road Ahead
By
Roger Brito, DO
;
Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN
;
Michael Kolodziej, MD
;
Barbara L. McAneny, MD
;
Steven Peskin, MD, MBA, FACP
;
Chevon Rariy, MD
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?
Read Bio
July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead
By
David DeRemer, PharmD, BCOP, FCCP, FHOPA
;
Michael Joyner, MD
;
Maurie Markman, MD
;
Kevin O’Hayer, MD, PhD
;
Bhavesh Shah, RPh, BCOP
;
Mark Sloan, MD
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?
Read Bio
May 27, 2020: An Actuarial View of COVID-19: Payers, Providers, Healthcare Reform: COVID-19 Impact on Cancer Care and Road to Recovery
By
Gabriela Dieguez, FSA, MAAA
;
Pamela Pelizzari, MPH
;
Bruce S. Pyenson, FSA, MAAA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
In this webcast, 3 experts from the independent actuarial firm, Milliman, discussed data on the impact of the COVID-19 pandemic on insurance utilization and costs. The panel explored several factors that may lead to healthcare reform in the months ahead, including the way in which patients and providers approach deferred or avoidable care.
Read Bio
May 22, 2020: Economic Observations: COVID-19 Impact on Cancer Care and Road to Recovery
By
Murray Aitken, MBA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
The COVID-19 pandemic will have far-reaching economic implications in the United States and abroad for the foreseeable future. During this session, Murray Aitken, MBA, Director, IQVIA Institute, presented emerging data regarding some of the ways in which the pandemic is affecting the US economy.
Read Bio
Page 2 of 4
1
2
3
4
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma